Derdack SMS messaging system improves productivity at Boehringer Ingelheim

Published: 5-Dec-2008
Manufacturing

Pharmaceutical company Boehringer Ingelheim has integrated Derdack's message master Enterprise Alert into its IT infrastructure and saved more than US$500,000 in lost productivity.


Pharmaceutical company Boehringer Ingelheim has integrated Derdack's message master Enterprise Alert into its IT infrastructure and saved more than US$500,000 in lost productivity.

The software is used to ensure maximum systems uptime and immediate rectification of faults.

Common faults include interruption to the power supply or the server room over-heating and this could lead to servers automatically shutting down.

Derdack's system is connected to an internal system that monitors the status of the servers and the uninterruptible power supply (UPS). If an event occurs, an alert is sent via SMS to a member of the on-call support team. The alert is escalated to the next person in the chain if message delivery fails or an acknowledgement is not received.

Jasper Zwarts, IT network engineer at Boehringer Ingelheim said: "By giving us the ability to solve problems before they affect our business users we have lowered our business risks and message master Enterprise Alert more than paid for itself after the first two faults were fixed.

"I would estimate that we have improved systems uptime by 1%," he added.

See more

You may also like

Manufacturing

Oxford BioTherapeutics and Boehringer Ingelheim extend cancer immunology partnership

Read more
The two companies have extended their existing collaboration by a further two years, aiming to develop novel cancer immunotherapies

Trending Articles

  1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
  2. Abselion launches AAVX and AAV9 Total Capsid Quantification Kits Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes
  3. diaago and Peak Analysis & Automation partner to bring practical automation solutions to research laboratories Using diaago's customer-first approach with PAA’s decades of expertise in laboratory robotics, the collaboration promises to deliver solutions to streamline workflows, boost throughput and reduce bottlenecks
  4. Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target
  5. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Manufacturing

Oxford BioTherapeutics and Boehringer Ingelheim extend cancer immunology partnership

The two companies have extended their existing collaboration by a further two years, aiming to develop novel cancer immunotherapies
Manufacturing

ProBioGen enters technology collaboration with Boehringer Ingelheim

It contributes to Boehringer Ingelheim's goal of using cutting-edge technologies across the whole biopharmaceutical value chain
Manufacturing

Bilfinger supports construction of Boehringer vaccine plant

The equipment, tailored to Boehringer’s specific customer requirements, includes 34 virus culture and downstream processing tanks as well as ready-to-use modules called skids
Manufacturing

Boehringer is first to take advantage of new Chinese regulations

Tislelizumab is the first biopharmaceutical manufactured by a multinational CDMO in China and the first commissioned under the new MAH model in the country
Design & Build

Boehringer Ingelheim opens Respimat plant in Catalonia

Facility in Sant Cugat, 30-minute drive northwest of Barcelona, will produce 25 million units per year; more than half the annual global Respimat sales
Manufacturing

Boehringer completes €105 million expansion for respiratory pipeline

Investment at sites in Dortmund and Ingelheim boost production capacity as next-gen inhaler Respimat hits the European market
Manufacturing

Boehringer Ingelheim wins China's first biopharmaceutical CMO pilot project

Boehringer Ingelheim China’s first client under the pilot is Beijing-based biotech company BeiGene
Subscribe now